NCT00751556View on ClinicalTrials.gov

Single/Multiple Dose Bioavailability Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Healthy
Interventions
DRUG

Naproxen Sodium 660mg

Extended release Naproxen Sodium (660mg) administered once a day

DRUG

Commercial Aleve 220 mg

Immediate release commercial Aleve (220 mg) administered in a 2 (440 mg) plus one (220 mg) dosing schedule, 660 mg total

Trial Locations (1)

72202

Little Rock

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY